On May 25th, the US Food and Drug Administration (FDA) issued warning letters to Shenzhen Xinyikang Technology Co., Ltd., the manufacturer of Esco Bars products, and Breeze Smoke, LLC, the importer and distributor of Breeze products.
The FDA has stated that these companies have been manufacturing, distributing, or importing unauthorized tobacco products in the United States, which is prohibited under the Federal Food, Drug, and Cosmetic (FD&C) Act. The FDA typically issues warning letters when investigating or inspecting initial violations. Most recipients of warning letters will correct the stated violations. However, failure to promptly correct violations may result in the FDA taking other actions, such as injunctions, seizures, and/or civil penalties.
On May 12, the FDA issued an import alert for Esco Bars products. The import alert places these tobacco products on a red list, allowing the FDA to refuse or detain the products upon entry and prevent illegal distribution within the United States.
Brian King, the director of the FDA's Center for Tobacco Products and a public health doctor, stated that companies that received warning letters have 15 days to respond to the FDA and outline how they plan to address their violations. If a company fails to adequately address their violations, the FDA may take a range of enforcement actions against them.
The following is the full text of the FDA announcement on their official website:
On May 25th, the US Food and Drug Administration (FDA) issued warning letters to two companies responsible for producing the popular disposable flavored electronic cigarette products Esco Bars and Breeze, which are manufactured by Shenzhen New Yikang Technology Co., Ltd. and imported and distributed by Breeze Smoke, LLC. The companies have been accused of manufacturing, distributing, and/or importing unauthorized tobacco products in the United States.
According to the 2022 National Youth Tobacco Survey, over 55% of current youth e-cigarette users most commonly use disposable e-cigarette products. Esco Bars and Breeze are currently the best-selling disposable product brands in the United States.
Today's actions underscored the FDA's commitment to protecting young people from the harms of illicit flavored disposable electronic cigarette products. On May 12th, the FDA also issued an import alert for Esco Bars products. The import alert places these tobacco products on a red list, allowing the FDA to refuse or detain the products upon entry and prevent illegal products from being distributed in the United States.
Dr. Brian King, director of the Tobacco Product Center at the FDA, stated that scientific evidence clearly shows that most young individuals who use e-cigarettes claim that they use disposable and flavored products. He further added that due to the appeal of such products to young individuals, they are the top priority for FDA compliance and enforcement actions.
Today, an e-cigarette company that produced, distributed or imported tobacco products without authorization from the FDA received a warning letter. This is a prohibited action under the Federal Food, Drug, and Cosmetic (FD&C) Act. The FDA typically issues warning letters when irregularities are first discovered during investigation or inspection. Most of the recipients of warning letters will correct the stated non-compliance. However, failure to timely correct non-compliant behavior may result in the FDA taking other actions, such as injunctions, seizure, and/or civil penalties.
We will continue to use all the tools in our regulatory toolbox to ensure that those who manufacture, distribute, or sell illegal e-cigarette products are held accountable," said Dr. Jin. "Companies who receive warning letters have 15 days to respond to the FDA, outlining how they will address the violations. If a company fails to adequately address the violations, we may take a range of enforcement actions against them.
So far, the FDA has authorized 23 tobacco-flavored e-cigarette products and devices. These are currently the only e-cigarette products that can be legally sold in the United States. Distribution or sales of illegally marketed products will be subject to law enforcement action.
The FDA is dedicated to protecting youth from the harms of tobacco products by ensuring that illegal products are not marketed, distributed, or sold. These efforts include ongoing monitoring of the market to identify non-compliant products, including e-cigarettes.
From January 2021 to May 19, 2023, the US Food and Drug Administration (FDA) has issued over 560 warning letters, proposed ten civil monetary penalties, and issued six injunctions to companies selling illegal electronic cigarettes. All of these actions are part of the FDA's ongoing efforts to enforce compliance and regulations, with updates on these actions being regularly reported. The FDA will continue to take action against anyone manufacturing, distributing, importing, or selling unauthorized electronic cigarette products, especially those most commonly used by youth.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
